Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)

NCT05156658 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
NETWORK
Sponsor class

Stopped Protocol's question was answered elsewhere and very low site interest in the trial

Conditions

Interventions

Sponsor

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

Collaborators